Chemical industry – Page 117
-
Business
Dow partners with Oz university
Dow is to partner with the University of Queensland in Australia
-
Business
Business roundup: April 2012
Pharmaceutical A pill to keep you off the pints? Source: © IStockphoto Beer today, gone tomorrow - Selincro tablets might help patients put their alcohol problems behind them Phase III trials of Selincro (nalmefene) tablets show that it outperforms placebo treatment when used to help patients with ...
-
Business
$500m for Ista
US eye drug company Bausch & Lomb has signed a cash deal to buy US drugmaker Ista Pharmaceuticals for $9.10 per share, equivalent to $500 million
-
Business
PCSK9 inhibitors against cholesterol problems perform well
Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins
-
Business
Light materials from Bayer
Bayer has launched a lightweight material designed to replace steel in railway locomotive and carriage construction
-
Business
AbbVie emerges from Abbott split
US healthcare giant Abbott has renamed the branded drugs part of its business
-
Business
EPA proposes new rules for five chemicals
The US Environmental Protection Agency has proposed new rules that would force companies to report any new use
-
Business
Court throws out patent covering drug dosing
The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented
-
Business
GSK to build £350m factory in UK
GlaxoSmithKline (GSK) has announced £350 million plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria
-
News
GSK to build £350 million factory in UK
Tax breaks in the UK budget have prompted GSK to reaffirm its commitment
-
News
India green lights production of patented cancer drug
For the first time India has invoked a ‘compulsory licence’ clause to cut the cost of a patented anti-cancer drug
-
Business
Children's lungs are more susceptible to nanoparticles
Infant lungs are particularly prone to nanoparticle deposition, be it from pollution or inhaled medicines
-
Business
Irish government plans to pick winners in research
Science funding will be targeted to areas that will deliver the biggest return on investment
-
Careers
To ECHA his own
The EU’s Reach regulation involves a huge data gathering operation - Kaihsu Tai is working right at its heart
-
BusinessMapping the reactivity of single nanocatalysts
The catalytic behaviour of gold nanorods varies across their surface in unexpected ways
-
BusinessNanocellulose has paper potential
Material would cut the carbon footprint of paper substantially – by 15% or more, the researchers say
-
FeatureRising from the ashes
Neil Sinclair reports on some exciting new ventures emerging from redundant chemical and pharmaceutical plants
-
OpinionThe elements of drug design
Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love
-
Business
Business roundup: March 2012
Pharmaceutical Collaboration for neglected tropical diseases A group of 13 pharma companies, three national governments and several global health organisations has come together to target 10 neglected tropical diseases (NTDs) with $785 million (?497 million) in R&D funding. The group aims to ’accelerate progress toward eliminating or controlling [this set ...
-
Opinion
The language of the lab
Derek Lowe wonders what the lab lingua franca might be in the years to come